Examples include February 4, 2020 (World Cancer Day), May 8, 2020 (United States Food and Drug Administration approval of Selpercatinib for advanced RET-driven lung and thyroid cancers), and September 1, 2020 (the first day of Thyroid Cancer Awareness Month). Here, RET is linked to thyroid gland carcinoma.